Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics.

Toshiaki ShimizuYoshiko NakayamaEizaburo IshiiShinobu IdaTomoki SatouDaisuke TokuharaKatsuhiro AraiMasahiro NiiHans RydholmToshitaka Yajimanull null
Published in: Pediatrics international : official journal of the Japan Pediatric Society (2019)
Oral esomeprazole, at 10 mg or 20 mg once daily, had a similar safety, efficacy, and pharmacokinetic profile in Japanese pediatric patients to that previously seen in adults and Caucasian children.